Document is current

Any future updates will be listed below

Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study

Crossref DOI link: https://doi.org/10.1007/s13300-018-0405-5

Published Online: 2018-03-14

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark